The PE Ratio as of December 2024 (TTM) for Onconova Therapeutics, Inc. (ONTX) is -1.04

According to Onconova Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.04. This represents a change of -92.01% compared to the average of -12.98 of the last 4 quarters.

Onconova Therapeutics, Inc. (ONTX) Historical PE Ratio (quarterly & annually)

How has ONTX PE Ratio performed in the past?

The mean historical PE Ratio of Onconova Therapeutics, Inc. over the last ten years is -23.33. The current -1.04 PE Ratio has changed 344.36% with respect to the historical average. Over the past ten years (40 quarters), ONTX's PE Ratio was at its highest in in the December 2015 quarter at 0. The PE Ratio was at its lowest in in the March 2021 quarter at -290.62.

Onconova Therapeutics, Inc. (ONTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Onconova Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Onconova Therapeutics, Inc. (ONTX) Average PE Ratio

How has ONTX PE Ratio performed in the past?

The current PE Ratio of Onconova Therapeutics, Inc. (ONTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Onconova Therapeutics, Inc. (ONTX) PE Ratio vs. Peers

How is ONTX’s PE Ratio compared to its peers?

Onconova Therapeutics, Inc.’s PE Ratio is less than Jaguar Health, Inc. (-0.24), less than iBio, Inc. (-0.89), less than GeoVax Labs, Inc. (-0.58), greater than Ocugen, Inc. (-4.26), less than Tonix Pharmaceuticals Holding Corp. (-0.18), less than Sonnet BioTherapeutics Holdings, Inc. (-0.18), less than Palisade Bio, Inc. (-0.19), less than Adial Pharmaceuticals, Inc. (-0.46), greater than Diffusion Pharmaceuticals Inc. (-1.68), less than Aeterna Zentaris Inc. (-0.10), greater than Pulmatrix, Inc. (-2.16), greater than Catalyst Biosciences, Inc. (-28.94), less than Bio-Path Holdings, Inc. (-0.34), less than Moleculin Biotech, Inc. (-0.22), greater than Vaxart, Inc. (-1.90), less than VBI Vaccines Inc. (-0.02),

Build a custom stock screener for Onconova Therapeutics, Inc. (ONTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconova Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Onconova Therapeutics, Inc. (ONTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Onconova Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.